OrthogenRx Information

OrthogenRx, Inc., now An Avanos Company, is a medical device company focused on the development and commercialization of treatments for musculoskeletal conditions including osteoarthritis (OA). Headquartered in Doylestown, PA, we are an early stage private medical device company. Our first product, GenVisc® 850 (sodium hyaluronate), is the only five injection hyaluronic acid product produced from non-avian source material. TriVisc is our 3 injection hyaluronic acid offering.

Website	http://www.orthogenrx.com
Revenue	$681.5 million
Employees	27 (2 on RocketReach)
Founded	2012
Address	2005 South Easton Road Suite 207, Doylestown, Pennsylvania 18901, US
Phone	+1 215-693-1066
Technologies	HTML , PHP , Google Analytics +13 more (view full list)
Industry	Medical Equipment Manufacturing, Biotechnology, Medical Devices, Science and Engineering, Pharmaceuticals, Commercial, Hyaluronic Acid, Health Care, Osteoarthritis, Medical Device, Viscosupplementation
Web Rank	22 Million
Keywords	Medical Devices, Osteoarthritis Treatment, Joint Pain Relief, Orthopedic Devices, Regenerative Medicine, Tissue Repair, Cartilage Regeneration, Bone Healing, Joint Health, Pain Management, Orthopedic Surgery, Sports Medicine, Physical Therapy, Rheumatology, Biologics, Medical Technology, Drug Delivery, Wound Healing, Mobility Solutions
Competitors	Zimmer Biomet, Amgen, Bioventus, Receptos, a wholly-owned subsidiary of Celgene, Sanofi, Meda, AstraZeneca, Marinomed Biotech AG, Regeneron, Sientra, Inc. +38 more (view full list)